×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Quince Therapeutics Inc. (QNCX) NASDAQ

$0.68 (0.03) (-4.23%)

Market Cap: $29.39M

As of 06/18/24 04:00 PM EDT. Market closed.

(QNCX)

Quince Therapeutics Inc. (QNCX)
NASDAQ

$0.68
(0.03) (-4.23%)

Market Cap: $29.39M

As of 06/18/24 04:00 PM EDT. Market closed.

Add to Portfolio

cortexyme is developing therapeutics based on data supporting a new theory of the cause of alzheimer's and other degenerative disorders. cortexyme is targeting a specific, undisclosed pathogen tied to neurodegeneration and beta amyloid production. the target has been validated in a number of animal models and cortexyme is currently moving a proprietary small molecule towards human clinical ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Address
.
PRICE CHART FOR QUINCE THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.70
Previous Close
$0.71
Days Range
$0.68 - $0.71
52 week range
$0.65 - $1.70
Volume
139,213
Avg. Volume (30 days)
131,925
Market Cap
$29.39M
Dividend Yield
-
P/E
-
Shares Outstanding
43,215,233
Open
$0.70
Previous Close
$0.71
Days Range
$0.68 - $0.71
52 week range
$0.65 - $1.70
Volume
139,213
Avg. Volume (30 days)
131,925
Market Cap
$29.39M
Dividend Yield
-
P/E
-
Shares Outstanding
43,215,233
FINANCIAL STATEMENTS FOR QUINCE THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR QUINCE THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Hannah BrendanCHIEF BUSINESS OFFICER AND COOJun 04, 2024 Option Exercise$0.5556,06130,834257,616Jun 05, 2024, 02:37 PM
Thye DirkCHIEF EXECUTIVE OFFICERJan 16, 2024 Option Exercise$0.79240,530190,791689,441Jan 17, 2024, 04:48 PM
Lamond DavidDirectorDec 13, 2023 Buy$1.0022,62722,6272,324,918Dec 14, 2023, 06:21 PM
Lamond DavidDirectorDec 12, 2023 Buy$1.0222,32722,7742,302,291Dec 14, 2023, 06:21 PM
Lamond DavidDirectorDec 12, 2023 Buy$1.003003002,279,964Dec 14, 2023, 06:21 PM
Lamond DavidDirectorDec 14, 2023 Buy$1.0422,62723,5322,347,545Dec 14, 2023, 06:21 PM
Lamond DavidDirectorDec 07, 2023 Buy$1.0119,12319,3142,279,664Dec 07, 2023, 06:30 PM
Lamond DavidDirectorDec 06, 2023 Buy$1.0219,12319,5052,260,541Dec 07, 2023, 06:30 PM
Lamond DavidDirectorDec 05, 2023 Buy$1.0119,12319,3142,241,418Dec 07, 2023, 06:30 PM
Lamond DavidDirectorNov 30, 2023 Buy$0.9014,37812,9402,207,917Dec 01, 2023, 01:38 PM
Lamond DavidDirectorNov 29, 2023 Buy$0.9814,37814,0902,193,539Dec 01, 2023, 01:38 PM
Lamond DavidDirectorDec 01, 2023 Buy$0.9414,37813,5152,222,295Dec 01, 2023, 01:38 PM
Lamond DavidDirectorAug 31, 2023 Buy$1.3241,02654,1542,179,161Aug 31, 2023, 06:42 PM
Lamond DavidDirectorAug 30, 2023 Buy$1.3141,02653,7442,138,135Aug 31, 2023, 06:42 PM
Lamond DavidDirectorAug 15, 2023 Buy$1.32107,886142,4101,954,995Aug 17, 2023, 06:08 PM
Lamond DavidDirectorAug 17, 2023 Buy$1.2924,76631,9482,097,109Aug 17, 2023, 06:08 PM
Lamond DavidDirectorAug 16, 2023 Buy$1.29117,348151,3792,072,343Aug 17, 2023, 06:08 PM
Thye DirkChief Executive OfficerAug 10, 2023 Buy$1.2688,000110,880448,911Aug 11, 2023, 04:15 PM
Thye DirkChief Executive OfficerAug 08, 2023 Buy$1.2480,00099,200360,911Aug 09, 2023, 06:23 PM
Hannah BrendanChief Business OfficerAug 08, 2023 Buy$1.2271,76287,550201,555Aug 09, 2023, 06:21 PM
McLoughlin MargaretDirectorAug 08, 2023 Buy$1.238,0009,8408,000Aug 09, 2023, 06:18 PM
Monohon TedChief Accounting Officer & VPMar 06, 2023 Sale$0.981,8711,83427,440Mar 06, 2023, 06:55 PM
Monohon TedChief Accounting Officer & VPDec 05, 2022 Option Exercise$0.721,6401,18129,311Dec 07, 2022, 05:37 PM
Monohon TedChief Accounting Officer & VPSep 06, 2022 Option Exercise$1.641,5202,49330,951Sep 08, 2022, 05:58 PM
Monohon TedChief Accounting Officer & VPJun 06, 2022 Option Exercise$3.121,5294,77032,471Jun 08, 2022, 04:13 PM
Holsinger LeslieEVP, Preclinical DevelopmentJun 06, 2022 Option Exercise$2.8610,92031,231148,080Jun 08, 2022, 04:10 PM
McDowell Caryn GordonChief Legal & Adm. OfficerJun 06, 2022 Option Exercise$2.866,70019,183133,300Jun 08, 2022, 04:09 PM
McDowell Caryn GordonChief Legal & Adm. OfficerJun 06, 2022 Sale$2.8610,80030,923122,500Jun 08, 2022, 04:09 PM
Lynch CaseyChief Executive OfficerNov 18, 2021 Option Exercise$0.4660,00027,600109,895Nov 19, 2021, 08:58 PM
LOWE CHRISTOPHER P.COO & Chief Financial OfficerNov 16, 2021 Option Exercise$2.2330,00066,90090,000Nov 16, 2021, 08:17 PM
Dominy Stephen S.Chief Scientific OfficerNov 12, 2021 Buy$14.4076310,9871,217,086Nov 12, 2021, 06:47 PM
McLoughlin MargaretDirectorOct 08, 2021 Option Exercise$17.001,00017,0001,000Oct 12, 2021, 05:48 PM
McLoughlin MargaretDirectorOct 08, 2021 Sale$88.931,00088,9300Oct 12, 2021, 05:48 PM
LOWE CHRISTOPHER P.COO & Chief Financial OfficerOct 05, 2021 Option Exercise$54.854,963272,22164,963Oct 07, 2021, 06:24 PM
LOWE CHRISTOPHER P.COO & Chief Financial OfficerOct 05, 2021 Sale$98.504,963488,85660,000Oct 07, 2021, 06:24 PM
McLoughlin MargaretDirectorAug 16, 2021 Option Exercise$17.006,000102,0006,000Aug 18, 2021, 05:30 PM
McLoughlin MargaretDirectorAug 16, 2021 Sale$95.446,000572,6442,944Aug 18, 2021, 05:30 PM
LOWE CHRISTOPHER P.COO & Chief Financial OfficerAug 17, 2021 Option Exercise$2.2330,00066,90060,000Aug 18, 2021, 05:25 PM
LOWE CHRISTOPHER P.COO & Chief Financial OfficerAug 16, 2021 Option Exercise$2.2322,00049,06052,000Aug 18, 2021, 05:25 PM
LOWE CHRISTOPHER P.COO & Chief Financial OfficerAug 16, 2021 Sale$95.3122,0002,096,77942,842Aug 18, 2021, 05:25 PM
Detke Michael J.Chief Medical OfficerAug 10, 2021 Option Exercise$2.2310,00022,30010,000Aug 12, 2021, 05:37 PM
Detke Michael J.Chief Medical OfficerAug 10, 2021 Sale$100.0010,0001,000,0000Aug 12, 2021, 05:37 PM
Detke Michael J.Chief Medical OfficerJul 07, 2021 Option Exercise$2.2317,40038,80217,400Jul 07, 2021, 08:38 PM
Detke Michael J.Chief Medical OfficerJul 06, 2021 Option Exercise$2.2312,60028,09840,861Jul 07, 2021, 08:38 PM
Detke Michael J.Chief Medical OfficerJul 06, 2021 Sale$53.5440,8612,187,6238,548Jul 07, 2021, 08:38 PM
Detke Michael J.Chief Medical OfficerJul 07, 2021 Sale$55.2017,400960,54913,466Jul 07, 2021, 08:38 PM
LOWE CHRISTOPHER P.COO & Chief Financial OfficerJun 30, 2021 Option Exercise$2.2330,00066,90030,000Jun 30, 2021, 05:46 PM
LOWE CHRISTOPHER P.COO & Chief Financial OfficerJun 28, 2021 Option Exercise$2.2320,00044,60020,000Jun 30, 2021, 05:46 PM
LOWE CHRISTOPHER P.COO & Chief Financial OfficerJun 28, 2021 Sale$54.1520,0001,083,07412,276Jun 30, 2021, 05:46 PM
McLoughlin MargaretDirectorJun 28, 2021 Sale$55.1555030,332350Jun 29, 2021, 05:26 PM
Lamond DavidDirectorMar 24, 2021 Buy$33.7750,0001,688,5001,847,109Mar 24, 2021, 09:06 PM
Lynch CaseyChief Executive OfficerMar 22, 2021 Sale$35.5930,0001,067,6111,027,563Mar 23, 2021, 07:06 PM
Lamond DavidDirectorMar 04, 2021 Buy$35.3450,0001,767,0571,797,109Mar 05, 2021, 05:54 PM
Lynch CaseyChief Executive OfficerFeb 01, 2021 Sale$36.2520,000724,9681,094,088Feb 03, 2021, 07:45 PM
Lynch CaseyChief Executive OfficerFeb 03, 2021 Sale$43.0320,000860,5301,058,374Feb 03, 2021, 07:45 PM
Lynch CaseyChief Executive OfficerFeb 02, 2021 Sale$36.2120,000724,1021,063,845Feb 03, 2021, 07:45 PM
Holsinger LeslieExecutive Vice PresidentDec 14, 2020 Option Exercise$0.2740,00010,80043,500Dec 15, 2020, 07:17 PM
Holsinger LeslieExecutive Vice PresidentDec 14, 2020 Sale$30.8140,0001,232,52841,800Dec 15, 2020, 07:17 PM
Holsinger LeslieExecutive Vice PresidentDec 10, 2020 Option Exercise$0.273,5009453,500Dec 14, 2020, 05:16 PM
EPIQ Capital Group, LLCIA/Managing Member of 10% OwneJun 12, 2020 Buy$44.062,440107,5062,860,967Jun 15, 2020, 06:55 PM
EPIQ Capital Group, LLCIA/Managing Member of 10% OwneJun 11, 2020 Buy$44.326,600292,5122,858,527Jun 15, 2020, 06:55 PM
Lamond DavidDirectorJun 04, 2020 Buy$43.2749,1252,125,7951,747,109Jun 08, 2020, 06:47 PM
PFIZER INC10% OwnerJun 03, 2020 Sale$40.18370,00014,866,6002,879,973Jun 04, 2020, 04:25 PM
Detke Michael J.Chief Medical OfficerMay 27, 2020 Option Exercise$6.915,51538,10928,261May 29, 2020, 04:48 PM
EPIQ Capital Group, LLCIA/Managing Member of 10% OwneMay 22, 2020 Buy$55.902,085116,5522,851,927May 22, 2020, 06:03 PM
EPIQ Capital Group, LLCIA/Managing Member of 10% OwneMay 21, 2020 Buy$55.8052029,0162,849,842May 22, 2020, 06:03 PM
EPIQ Capital Group, LLCIA/Managing Member of 10% OwneMay 20, 2020 Buy$57.956,085352,6052,849,322May 22, 2020, 06:03 PM
Lamond DavidDirectorMay 15, 2020 Buy$48.935,448266,5691,658,784May 19, 2020, 06:41 PM
Lamond DavidDirectorMay 19, 2020 Buy$56.2439,2002,204,6831,697,984May 19, 2020, 06:41 PM
Detke Michael J.Chief Medical OfficerApr 02, 2020 Option Exercise$6.915,51538,10922,746Apr 06, 2020, 05:39 PM
YOUNG KEVINDirectorMay 13, 2019 Buy$17.0030,000510,00030,000Mar 12, 2020, 04:46 PM
RYAN UNA SDirectorMay 13, 2019 Buy$17.002,87548,8752,875Mar 12, 2020, 04:43 PM
McLoughlin MargaretDirectorMay 13, 2019 Buy$17.005509,350550Mar 12, 2020, 04:40 PM
Lamond DavidDirectorFeb 10, 2020 Option Exercise$50.0030,0001,500,0001,653,336Feb 10, 2020, 06:18 PM
Detke Michael J.Chief Medical OfficerFeb 07, 2020 Option Exercise$6.9117,231119,06617,231Feb 10, 2020, 06:15 PM
EPIQ Capital Group, LLCIA/Managing Member of 10% OwneJan 29, 2020 Option Exercise$54.304,338235,5532,843,237Jan 31, 2020, 01:40 PM
EPIQ Capital Group, LLCIA/Managing Member of 10% owneAug 21, 2019 Buy$24.871,63540,6602,847,575Nov 29, 2019, 01:07 PM
EPIQ Capital Group, LLCIA/Managing Member of 10% owneAug 21, 2019 Buy$24.8742010,4452,845,940Nov 29, 2019, 01:07 PM
EPIQ Capital Group, LLCIA/Managing Member of 10% owneAug 20, 2019 Buy$25.692,31059,3442,845,520Nov 29, 2019, 01:07 PM
EPIQ Capital Group, LLCIA/Managing Member of 10% owneAug 20, 2019 Buy$25.6960015,4142,843,210Nov 29, 2019, 01:07 PM
EPIQ Capital Group, LLCIA/Managing Member of 10% owneAug 16, 2019 Buy$26.3770018,4602,840,510Nov 29, 2019, 12:59 PM
EPIQ Capital Group, LLCIA/Managing Member of 10% owneAug 19, 2019 Buy$26.502,10055,6402,842,610Nov 29, 2019, 12:59 PM
EPIQ Capital Group, LLCIA/Managing Member of 10% owneMay 10, 2019 Buy$27.05802,1642,839,810Nov 29, 2019, 12:52 PM
EPIQ Capital Group, LLCIA/Managing Member of 10% owneMay 10, 2019 Buy$27.584,170115,0092,839,730Nov 29, 2019, 12:52 PM
EPIQ Capital Group, LLCIA/Managing Member of 10% owneMay 10, 2019 Buy$26.414,350114,8832,835,560Nov 29, 2019, 12:52 PM
EPIQ Capital Group, LLCIA/Managing Member 10% ownerAug 20, 2019 Buy$25.692,31059,3442,832,506Aug 21, 2019, 04:54 PM
EPIQ Capital Group, LLCIA/Managing Member 10% ownerAug 20, 2019 Buy$25.6960015,4142,830,196Aug 21, 2019, 04:54 PM
EPIQ Capital Group, LLCIA/Managing Member 10% ownerAug 21, 2019 Buy$24.871,63540,6602,834,561Aug 21, 2019, 04:54 PM
EPIQ Capital Group, LLCIA/Managing Member 10% ownerAug 21, 2019 Buy$24.8742010,4452,832,926Aug 21, 2019, 04:54 PM
EPIQ Capital Group, LLCIA/Managing Member 10% ownerAug 19, 2019 Buy$26.502,10055,6402,829,596Aug 19, 2019, 05:10 PM
EPIQ Capital Group, LLCIA/Managing Member 10% ownerAug 16, 2019 Buy$26.3770018,4602,827,496Aug 19, 2019, 05:10 PM
EPIQ Capital Group, LLCIA/Managing Member 10% ownerMay 10, 2019 Buy$27.05802,1642,826,796Jun 14, 2019, 12:48 PM
EPIQ Capital Group, LLCIA/Managing Member 10% ownerMay 10, 2019 Buy$27.584,170115,0092,826,716Jun 14, 2019, 12:48 PM
EPIQ Capital Group, LLCIA/Managing Member 10% ownerMay 10, 2019 Buy$26.414,350114,8832,822,546Jun 14, 2019, 12:48 PM
PFIZER INC10% OwnerMay 13, 2019 Buy$17.0050,000850,0003,249,973May 14, 2019, 07:34 AM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Hannah BrendanCHIEF BUSINESS OFFICER AND COO06/04/202430,834
Thye DirkCHIEF EXECUTIVE OFFICER01/16/2024190,791
Lamond DavidDirector12/13/202322,627
Lamond DavidDirector12/12/202322,774
Lamond DavidDirector12/12/2023300
Lamond DavidDirector12/14/202323,532
Lamond DavidDirector12/07/202319,314
Lamond DavidDirector12/06/202319,505
Lamond DavidDirector12/05/202319,314
Lamond DavidDirector11/30/202312,940
Lamond DavidDirector11/29/202314,090
Lamond DavidDirector12/01/202313,515
Lamond DavidDirector08/31/202354,154
Lamond DavidDirector08/30/202353,744
Lamond DavidDirector08/15/2023142,410
Lamond DavidDirector08/17/202331,948
Lamond DavidDirector08/16/2023151,379
Thye DirkChief Executive Officer08/10/2023110,880
Thye DirkChief Executive Officer08/08/202399,200
Hannah BrendanChief Business Officer08/08/202387,550
McLoughlin MargaretDirector08/08/20239,840
Monohon TedChief Accounting Officer & VP03/06/20231,834
Monohon TedChief Accounting Officer & VP12/05/20221,181
Monohon TedChief Accounting Officer & VP09/06/20222,493
Monohon TedChief Accounting Officer & VP06/06/20224,770
Holsinger LeslieEVP, Preclinical Development06/06/202231,231
McDowell Caryn GordonChief Legal & Adm. Officer06/06/202219,183
McDowell Caryn GordonChief Legal & Adm. Officer06/06/202230,923
Lynch CaseyChief Executive Officer11/18/202127,600
LOWE CHRISTOPHER P.COO & Chief Financial Officer11/16/202166,900
Dominy Stephen S.Chief Scientific Officer11/12/202110,987
McLoughlin MargaretDirector10/08/202117,000
McLoughlin MargaretDirector10/08/202188,930
LOWE CHRISTOPHER P.COO & Chief Financial Officer10/05/2021272,221
LOWE CHRISTOPHER P.COO & Chief Financial Officer10/05/2021488,856
McLoughlin MargaretDirector08/16/2021102,000
McLoughlin MargaretDirector08/16/2021572,644
LOWE CHRISTOPHER P.COO & Chief Financial Officer08/17/202166,900
LOWE CHRISTOPHER P.COO & Chief Financial Officer08/16/202149,060
LOWE CHRISTOPHER P.COO & Chief Financial Officer08/16/20212,096,779
Detke Michael J.Chief Medical Officer08/10/202122,300
Detke Michael J.Chief Medical Officer08/10/20211,000,000
Detke Michael J.Chief Medical Officer07/07/202138,802
Detke Michael J.Chief Medical Officer07/06/202128,098
Detke Michael J.Chief Medical Officer07/06/20212,187,623
Detke Michael J.Chief Medical Officer07/07/2021960,549
LOWE CHRISTOPHER P.COO & Chief Financial Officer06/30/202166,900
LOWE CHRISTOPHER P.COO & Chief Financial Officer06/28/202144,600
LOWE CHRISTOPHER P.COO & Chief Financial Officer06/28/20211,083,074
McLoughlin MargaretDirector06/28/202130,332
Lamond DavidDirector03/24/20211,688,500
Lynch CaseyChief Executive Officer03/22/20211,067,611
Lamond DavidDirector03/04/20211,767,057
Lynch CaseyChief Executive Officer02/01/2021724,968
Lynch CaseyChief Executive Officer02/03/2021860,530
Lynch CaseyChief Executive Officer02/02/2021724,102
Holsinger LeslieExecutive Vice President12/14/202010,800
Holsinger LeslieExecutive Vice President12/14/20201,232,528
Holsinger LeslieExecutive Vice President12/10/2020945
EPIQ Capital Group, LLCIA/Managing Member of 10% Owne06/12/2020107,506
EPIQ Capital Group, LLCIA/Managing Member of 10% Owne06/11/2020292,512
Lamond DavidDirector06/04/20202,125,795
PFIZER INC10% Owner06/03/202014,866,600
Detke Michael J.Chief Medical Officer05/27/202038,109
EPIQ Capital Group, LLCIA/Managing Member of 10% Owne05/22/2020116,552
EPIQ Capital Group, LLCIA/Managing Member of 10% Owne05/21/202029,016
EPIQ Capital Group, LLCIA/Managing Member of 10% Owne05/20/2020352,605
Lamond DavidDirector05/15/2020266,569
Lamond DavidDirector05/19/20202,204,683
Detke Michael J.Chief Medical Officer04/02/202038,109
YOUNG KEVINDirector05/13/2019510,000
RYAN UNA SDirector05/13/201948,875
McLoughlin MargaretDirector05/13/20199,350
Lamond DavidDirector02/10/20201,500,000
Detke Michael J.Chief Medical Officer02/07/2020119,066
EPIQ Capital Group, LLCIA/Managing Member of 10% Owne01/29/2020235,553
EPIQ Capital Group, LLCIA/Managing Member of 10% owne08/21/201940,660
EPIQ Capital Group, LLCIA/Managing Member of 10% owne08/21/201910,445
EPIQ Capital Group, LLCIA/Managing Member of 10% owne08/20/201959,344
EPIQ Capital Group, LLCIA/Managing Member of 10% owne08/20/201915,414
EPIQ Capital Group, LLCIA/Managing Member of 10% owne08/16/201918,460
EPIQ Capital Group, LLCIA/Managing Member of 10% owne08/19/201955,640
EPIQ Capital Group, LLCIA/Managing Member of 10% owne05/10/20192,164
EPIQ Capital Group, LLCIA/Managing Member of 10% owne05/10/2019115,009
EPIQ Capital Group, LLCIA/Managing Member of 10% owne05/10/2019114,883
EPIQ Capital Group, LLCIA/Managing Member 10% owner08/20/201959,344
EPIQ Capital Group, LLCIA/Managing Member 10% owner08/20/201915,414
EPIQ Capital Group, LLCIA/Managing Member 10% owner08/21/201940,660
EPIQ Capital Group, LLCIA/Managing Member 10% owner08/21/201910,445
EPIQ Capital Group, LLCIA/Managing Member 10% owner08/19/201955,640
EPIQ Capital Group, LLCIA/Managing Member 10% owner08/16/201918,460
EPIQ Capital Group, LLCIA/Managing Member 10% owner05/10/20192,164
EPIQ Capital Group, LLCIA/Managing Member 10% owner05/10/2019115,009
EPIQ Capital Group, LLCIA/Managing Member 10% owner05/10/2019114,883
PFIZER INC10% Owner05/13/2019850,000
Load More Insider Transactions
FUNDS WITH A POSITION IN QUINCE THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RENAISSANCE TECHNOLOGIES LLC520,1000.00087%13.39%Other
BLACKROCK INC.332,0860.00001%-1.05%Other
GEODE CAPITAL MANAGEMENT, LLC266,8960.00003%1.97%Other
CHANGE IN SHARES OUTSTANDING FOR QUINCE THERAPEUTICS INC
STOCK BUYBACKS FOR QUINCE THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
12/31/2023
4.58%
1Q
03/31/2024
09/30/2023
19.23%
2Q
03/31/2024
06/30/2023
19.75%
3Q
03/31/2024
03/31/2023
19.96%
4Q
03/31/2024
12/31/2022
20.44%
5Q
03/31/2024
09/30/2022
20.77%
6Q
03/31/2024
06/30/2022
32.47%
7Q
03/31/2024
03/31/2022
42.73%
8Q
03/31/2024
12/31/2021
43.55%
9Q
03/31/2024
09/30/2021
44.49%
10Q
03/31/2024
06/30/2021
45.37%
11Q
03/31/2024
03/31/2021
45.53%
12Q
03/31/2024
12/31/2020
45.76%
13Q
03/31/2024
09/30/2020
45.85%
14Q
03/31/2024
06/30/2020
46.08%
15Q
03/31/2024
03/31/2020
52.19%
16Q
Load More

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2023
4.58%
1Q
09/30/2023
19.23%
2Q
06/30/2023
19.75%
3Q
03/31/2023
19.96%
4Q
12/31/2022
20.44%
5Q
09/30/2022
20.77%
6Q
06/30/2022
32.47%
7Q
03/31/2022
42.73%
8Q
12/31/2021
43.55%
9Q
09/30/2021
44.49%
10Q
06/30/2021
45.37%
11Q
03/31/2021
45.53%
12Q
12/31/2020
45.76%
13Q
09/30/2020
45.85%
14Q
06/30/2020
46.08%
15Q
03/31/2020
52.19%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR QUINCE THERAPEUTICS INC
LOADING...